Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
INAGEN ApS
APS
In liquidation
Reklamebeskyttelse
CVR 30721632
Kongevejen 371, 2840
Holte
Forskning og eksperimentel udvikling indenfor bioteknologi
·
NACE 721100
Est. 2007 · 18 years old
— employees
Overvåg
Share
Denmark
/
Companies
/
Forskning og eksperimentel udvikling indenfor bioteknologi
/
INAGEN ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Former (3)
TN
Thomas Nitschke Kledal
Chief Executive Officer
Chief Executive Officer
2008 – 2015
JB
Jan Bjerrum Bach
Unofficial title
Unofficial title
2015 – 2016
MM
Mette Marie Rosenkilde
Founder
Founder
2007 – 2016
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Former (6)
JS
Jørgen Søberg Petersen
Board of Directors
Board of Directors
2007 – 2008
SA
Sean Arthur Macdonald
Board of Directors
Board of Directors
2007 – 2007
LH
Leif Helth Jensen
Board of Directors
Board of Directors
2008 – 2014
SC
Stephan Christgau
Chairman
Chairman
2012 – 2015
CE
Christian Ellebæk Elling
Board of Directors
Board of Directors
2007 – 2012
PS
Peter Samuel Wulff
Chairman
Chairman
2008 – 2012
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
TNK BIOTECH ApS
Company
10–14.99%
10–14.99%
2007
Novo Holdings A/S
Company
50–66.65%
50–66.65%
2009
CAT SEED A/S
Company
20–24.99%
20–24.99%
2009
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on INAGEN ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network